• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, February 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Yale-led team examines impact of diet intervention on autoimmunity in mice

Bioengineer by Bioengineer
December 20, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New Haven, Conn. — Could a change in diet be beneficial to people with autoimmune diseases such as lupus? A Yale-led team of researchers have revealed how a dietary intervention can help prevent the development of this autoimmune disease in susceptible mice. The study was published in Cell Host & Microbe.

For the study, led by Yale immunobiologist Martin Kriegel, the research team used mouse models of lupus. They first identified a single bacterium, Lactobacillus reuteri, in the gut of the mice that triggered an immune response leading to the disease. Specifically, in lupus-prone mice, L. reuteri stimulated immune cells known as dendritic cells, as well as immune system pathways that exacerbated disease development.

To investigate the potential impact of diet on this process, first author Daniel Zegarra-Ruiz fed the mice “resistant starch” — a diet that mimics a high-fiber diet in humans. The resistant starch is not absorbed in the small intestine but ferments in the large intestine, enriching good bacteria and causing the secretion of short-chain fatty acids. This, in turn, suppresses both the growth and movement of L. reuteri bacteria outside the gut that would otherwise lead to autoimmune disease.

While more research is needed to discern how the findings translate to humans, the study details an important link between diet, gut bacteria, and autoimmunity. “We dissected, molecularly, how diets can work on the gut microbiome,” said Kriegel. “We identified a pathway that is driving autoimmune disease and mitigated by the diet.”

The study also found an imbalance of gut microbes in a subset of lupus patients that was similar to what they observed in lupus-prone mice not given the starch diet. In this subset of lupus patients, the high-fiber diet could potentially be beneficial to prevent or ameliorate the condition, in addition to other diseases that activate the same immune pathway, Kriegel noted. “It may have implications beyond lupus.”

###

Other authors are Asmaa El Beidaq, Alonso J. Iñiguez, Martina Lubrano DiRicco, Silvio Manfredo Vieira, William E. Ruff, Derek Mubiru, Rebecca L. Fine, John Sterpka, Teri M. Greiling, and Carina Dehner.

This work was supported by grants from the National Institutes of Health, the O’Brien Center at Yale, the Arthritis National Research Foundation, the Arthritis Foundation, the Lupus Research Institute, and the Lupus Foundation of America.

Citation: Cell Host & Microbe

Media Contact
Ziba Kashef
 @yale

203-436-9317

Tags: BacteriologyImmunology/Allergies/AsthmaMedicine/HealthNutrition/Nutrients
Share12Tweet8Share2ShareShareShare2

Related Posts

Forensic Protein Analysis Reveals Time Since Death

February 2, 2026

Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial

February 2, 2026

Circulating Progenitor Cells Detect and Repair Aberrant Cells

February 2, 2026

MME Identified as Key Target of Notoginsenoside R1

February 2, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    157 shares
    Share 63 Tweet 39
  • Robotic Ureteral Reconstruction: A Novel Approach

    81 shares
    Share 32 Tweet 20
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Forensic Protein Analysis Reveals Time Since Death

Unraveling Genome Growth in Acyclania tenebrosa

Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.